US Azelaic Acid Market

ID: MRFR/CnM/19114-HCR 111 Pages Chitranshi Jaiswal Last Updated: August 24, 2026
US Azelaic Acid Market Research Report: By Product Type (Polymer Grade, Technical Grade, Pharmaceutical Grade) and By Application (Plastics, Lubricants, Electronics, Pharmaceuticals and Cosmetics, Personal Care, Other Applications) - Forecast to 2035. US Azelaic Acid Market Research Report: By Product Type (Polymer Grade, Technical Grade, Pharmaceutical Grade) and By Application (Plastics, Lubricants, Electronics, Pharmaceuticals and Cosmetics, Personal Care, Other Applications) - Forecast to 2035
US Azelaic Acid Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.17%
2024 Market Size$ 59.5 Million
2025 Market Size$ 63.77 Million
2035 Market Size$ 127.5 Million
Key Players
BASF SE
Galderma S.A.
Almirall S.A.
Mylan N.V.
Fujifilm Diosynth Biotechnologies
Sientra
Trends
  • Rising Demand for Natural Ingredients
  • Increased Focus on Dermatological Applications
  • Expansion of E-commerce Channels
Opportunities
  • Growing Awareness of Skin Health
  • Rising Incidence of Skin Disorders
  • Innovation in Formulation Technologies
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Application (USD Million)
      1. 4.1.1 Dermatology
      2. 4.1.2 Cosmetic
      3. 4.1.3 Pharmaceutical
      4. 4.1.4 Research
      5. 4.1.5 Industrial
    2. 4.2 Chemicals and Materials, BY Formulation Type (USD Million)
      1. 4.2.1 Cream
      2. 4.2.2 Gel
      3. 4.2.3 Foam
      4. 4.2.4 Lotion
      5. 4.2.5 Solution
    3. 4.3 Chemicals and Materials, BY End Use (USD Million)
      1. 4.3.1 Acne Treatment
      2. 4.3.2 Rosacea Treatment
      3. 4.3.3 Skin Lightening
      4. 4.3.4 Anti-Aging
      5. 4.3.5 Hyperpigmentation
    4. 4.4 Chemicals and Materials, BY Distribution Channel (USD Million)
      1. 4.4.1 Online
      2. 4.4.2 Pharmacy
      3. 4.4.3 Supermarket
      4. 4.4.4 Specialty Store
      5. 4.4.5 Direct Sales
    5. 4.5 Chemicals and Materials, BY Customer Type (USD Million)
      1. 4.5.1 Retail Consumers
      2. 4.5.2 Healthcare Professionals
      3. 4.5.3 Pharmaceutical Companies
      4. 4.5.4 Cosmetic Manufacturers
      5. 4.5.5 Research Institutions
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Galderma (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Almirall (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bausch Health (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Mylan (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Fougera Pharmaceuticals (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Perrigo (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Hikma Pharmaceuticals (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Aclaris Therapeutics (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY APPLICATION
    3. 6.3 US MARKET ANALYSIS BY FORMULATION TYPE
    4. 6.4 US MARKET ANALYSIS BY END USE
    5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. 6.6 US MARKET ANALYSIS BY CUSTOMER TYPE
    7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    13. 6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 (% SHARE)
    16. 6.16 CHEMICALS AND MATERIALS, BY FORMULATION TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
    18. 6.18 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
    19. 6.19 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    20. 6.20 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    21. 6.21 CHEMICALS AND MATERIALS, BY CUSTOMER TYPE, 2024 (% SHARE)
    22. 6.22 CHEMICALS AND MATERIALS, BY CUSTOMER TYPE, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY END USE, 2025-2035 (USD Million)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
      5. 7.2.5 BY CUSTOMER TYPE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Azelaic Acid Market Segmentation

US Azelaic Acid Market By Application (USD Million, 2025-2035)

  • Dermatology
  • Cosmetic
  • US Azelaic Acid Market
  • Research
  • Industrial

US Azelaic Acid Market By Formulation Type (USD Million, 2025-2035)

  • Cream
  • Gel
  • Foam
  • Lotion
  • Solution

US Azelaic Acid Market By End Use (USD Million, 2025-2035)

  • Acne Treatment
  • Rosacea Treatment
  • Skin Lightening
  • Anti-Aging
  • Hyperpigmentation

US Azelaic Acid Market By Distribution Channel (USD Million, 2025-2035)

  • Online
  • Pharmacy
  • Supermarket
  • Specialty Store
  • Direct Sales

US Azelaic Acid Market By Customer Type (USD Million, 2025-2035)

  • Retail Consumers
  • Healthcare Professionals
  • US Azelaic Acid Market Companies
  • Cosmetic Manufacturers
  • Research Institutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.